AdipoGen Life Sciences

anti-IL-33 (mouse), pAb

CHF 450.00

In stock

AG-25A-0047-C100100 µgCHF 450.00

Figure 1: Western blot analysis using anti-IL-33 (mouse), pAb (Prod. No. AG-25A-0047) at 1:2'000 dilution.
1: Mouse IL-33 (His-tagged).
2: Human IL-33 (His-tagged).
3: Unrelated protein (His-tagged) (negative control).

Specifications / Handling

More Information
Product Details
Synonyms	Interleukin-33; IL-1F11; NF-HEV
Product Type	Polyclonal Antibody
Properties
Source/Host	Rabbit
Immunogen/Antigen	Recombinant mouse IL-33.
Application	ELISA: (direct and indirect: 1:2’000-1:5’000) Western Blot: (1:2’000-1:5’000 using ECL; suggested blocking and dilution buffer is PBST containing 0.05% Tween 20 and 5% skim milk; suggested incubation time is 1 hour at room temperature). Optimal conditions must be determined individually for each application.
Crossreactivity	Mouse
Specificity	Recognizes mouse IL-33. Detects a band of ~18kDa by Western blot. Does not cross-react with human IL-33.
Purity Detail	Protein A-affinity purified.
Concentration	1mg/ml
Formulation	Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
Isotype Negative Control	Rabbit IgG
Shipping and Handling
Shipping	BLUE ICE
Short Term Storage	+4°C
Long Term Storage	-20°C
Handling Advice	After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles.
Use/Stability	Stable for at least 6 months after receipt when stored at -20°C.
Documents
MSDS	Download PDF
Product Specification Sheet
Datasheet	Download PDF

Product-specific References

Description

Interleukin-33 (IL-33; HF-NEV; IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30kDa human IL33 is converted by CASP1 to a 18kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.

Product References

Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation: H. Hayakawa, et al.; JBC 282, 26369 (2007)
A novel method for procuring a large quantity of mature murine eosinophils in vivo: W. Kim, et al.; J. Immunol. Methods 363, 90 (2010)

Call	+41 61 926 6040
Fax	+41 61 926 6049